Matches in SemOpenAlex for { <https://semopenalex.org/work/W2616449719> ?p ?o ?g. }
- W2616449719 abstract "Mus musculus papillomavirus 1 (MmuPV1/MusPV1) induces persistent papillomas in immunodeficient mice but not in common laboratory strains. To facilitate the study of immune control, we sought an outbred and immunocompetent laboratory mouse strain in which persistent papillomas could be established. We found that challenge of SKH1 mice (Crl:SKH1-Hrhr) with MmuPV1 by scarification on their tail resulted in three clinical outcomes: (i) persistent (>2-month) papillomas (∼20%); (ii) transient papillomas that spontaneously regress, typically within 2 months (∼15%); and (iii) no visible papillomas and viral clearance (∼65%). SKH1 mice with persistent papillomas were treated by using a candidate preventive/therapeutic naked-DNA vaccine that expresses human calreticulin (hCRT) fused in frame to MmuPV1 E6 (mE6) and mE7 early proteins and residues 11 to 200 of the late protein L2 (hCRTmE6/mE7/mL2). Three intramuscular DNA vaccinations were delivered biweekly via in vivo electroporation, and both humoral and CD8 T cell responses were mapped and measured. Previously persistent papillomas disappeared within 2 months after the final vaccination. Coincident virologic clearance was confirmed by in situ hybridization and a failure of disease to recur after CD3 T cell depletion. Vaccination induced strong mE6 and mE7 CD8+ T cell responses in all mice, although they were significantly weaker in mice that initially presented with persistent warts than in those that spontaneously cleared their infection. A human papillomavirus 16 (HPV16)-targeted version of the DNA vaccine also induced L2 antibodies and protected mice from vaginal challenge with an HPV16 pseudovirus. Thus, MmuPV1 challenge of SKH1 mice is a promising model of spontaneous and immunotherapy-directed clearances of HPV-related disease.IMPORTANCE High-risk-type human papillomaviruses (hrHPVs) cause 5% of all cancer cases worldwide, notably cervical, anogenital, and oropharyngeal cancers. Since preventative HPV vaccines have not been widely used in many countries and do not impact existing infections, there is considerable interest in the development of therapeutic vaccines to address existing disease and infections. The strict tropism of HPV requires the use of animal papillomavirus models for therapeutic vaccine development. However, MmuPV1 failed to grow in common laboratory strains of mice with an intact immune system. We show that MmuPV1 challenge of the outbred immunocompetent SKH1 strain produces both transient and persistent papillomas and that vaccination of the mice with a DNA expressing an MmuPV1 E6E7L2 fusion with calreticulin can rapidly clear persistent papillomas. Furthermore, an HPV16-targeted version of the DNA can protect against vaginal challenge with HPV16, suggesting the promise of this approach to both prevent and treat papillomavirus-related disease." @default.
- W2616449719 created "2017-05-26" @default.
- W2616449719 creator A5003590988 @default.
- W2616449719 creator A5008032475 @default.
- W2616449719 creator A5008662155 @default.
- W2616449719 creator A5010820722 @default.
- W2616449719 creator A5017307827 @default.
- W2616449719 creator A5024057833 @default.
- W2616449719 creator A5048706158 @default.
- W2616449719 creator A5062803843 @default.
- W2616449719 creator A5075860092 @default.
- W2616449719 creator A5089035026 @default.
- W2616449719 creator A5016805906 @default.
- W2616449719 date "2017-08-01" @default.
- W2616449719 modified "2023-10-16" @default.
- W2616449719 title "Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection" @default.
- W2616449719 cites W1518048883 @default.
- W2616449719 cites W1534640705 @default.
- W2616449719 cites W1571709151 @default.
- W2616449719 cites W1574596120 @default.
- W2616449719 cites W1688526230 @default.
- W2616449719 cites W1757407923 @default.
- W2616449719 cites W1966711839 @default.
- W2616449719 cites W1967204131 @default.
- W2616449719 cites W1973629456 @default.
- W2616449719 cites W1976787926 @default.
- W2616449719 cites W1979392487 @default.
- W2616449719 cites W1981725818 @default.
- W2616449719 cites W1981734767 @default.
- W2616449719 cites W1983062261 @default.
- W2616449719 cites W1987350137 @default.
- W2616449719 cites W1991233227 @default.
- W2616449719 cites W1993877349 @default.
- W2616449719 cites W1995404189 @default.
- W2616449719 cites W1997729487 @default.
- W2616449719 cites W1999409141 @default.
- W2616449719 cites W2006027817 @default.
- W2616449719 cites W2014407124 @default.
- W2616449719 cites W2018715070 @default.
- W2616449719 cites W2028907068 @default.
- W2616449719 cites W2029997802 @default.
- W2616449719 cites W2036641307 @default.
- W2616449719 cites W2039442454 @default.
- W2616449719 cites W2052516166 @default.
- W2616449719 cites W2052649413 @default.
- W2616449719 cites W2058151611 @default.
- W2616449719 cites W2061829061 @default.
- W2616449719 cites W2064273388 @default.
- W2616449719 cites W2065695118 @default.
- W2616449719 cites W2067102830 @default.
- W2616449719 cites W2068298191 @default.
- W2616449719 cites W2069143946 @default.
- W2616449719 cites W2071686791 @default.
- W2616449719 cites W2072617110 @default.
- W2616449719 cites W2080731494 @default.
- W2616449719 cites W2082179624 @default.
- W2616449719 cites W2082815122 @default.
- W2616449719 cites W2089899954 @default.
- W2616449719 cites W2093480157 @default.
- W2616449719 cites W2097206817 @default.
- W2616449719 cites W2098765233 @default.
- W2616449719 cites W2099199536 @default.
- W2616449719 cites W2100352133 @default.
- W2616449719 cites W2101196984 @default.
- W2616449719 cites W2108134987 @default.
- W2616449719 cites W2108450719 @default.
- W2616449719 cites W2113960129 @default.
- W2616449719 cites W2117184512 @default.
- W2616449719 cites W2125726678 @default.
- W2616449719 cites W2126246455 @default.
- W2616449719 cites W2127982502 @default.
- W2616449719 cites W2128471759 @default.
- W2616449719 cites W2139349670 @default.
- W2616449719 cites W2140014254 @default.
- W2616449719 cites W2140336275 @default.
- W2616449719 cites W2140481064 @default.
- W2616449719 cites W2141274038 @default.
- W2616449719 cites W2142809889 @default.
- W2616449719 cites W2145426305 @default.
- W2616449719 cites W2148422519 @default.
- W2616449719 cites W2148870453 @default.
- W2616449719 cites W2150436558 @default.
- W2616449719 cites W2155070784 @default.
- W2616449719 cites W2160808472 @default.
- W2616449719 cites W2168690984 @default.
- W2616449719 cites W2169183151 @default.
- W2616449719 cites W2175844702 @default.
- W2616449719 cites W22520275 @default.
- W2616449719 cites W2276203028 @default.
- W2616449719 cites W2336929005 @default.
- W2616449719 cites W2406647733 @default.
- W2616449719 cites W2413989238 @default.
- W2616449719 cites W2559662677 @default.
- W2616449719 cites W2577561171 @default.
- W2616449719 cites W2586267950 @default.
- W2616449719 cites W2591195655 @default.
- W2616449719 cites W303337234 @default.
- W2616449719 cites W4235081779 @default.
- W2616449719 cites W761036793 @default.
- W2616449719 doi "https://doi.org/10.1128/jvi.00699-17" @default.